Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
52
PPB:25
NMPA:14
SFDA:13
Drug Approvals
Brimonidine Tartrate and Timolol Maleate Eye Drops
- Product Name
- 溴莫尼定噻吗洛尔滴眼液
- Approval Number
- 国药准字HJ20140928
- Approval Date
- Oct 29, 2024
NMPA
Carboxymethylcellulose Sodium Eye Drops
- Product Name
- 羧甲基纤维素钠滴眼液
- Approval Number
- 国药准字HJ20140945
- Approval Date
- Aug 26, 2024
NMPA
Carboxymethylcellulose Sodium Eye Drops
- Product Name
- 潇莱威
- Approval Number
- 国药准字HJ20140946
- Approval Date
- Aug 26, 2024
NMPA
Prednisolone Acetate Ophthalmic Suspension
- Product Name
- 百力特
- Approval Number
- 国药准字HJ20171243
- Approval Date
- Nov 4, 2022
NMPA
Prednisolone Acetate Ophthalmic Suspension
- Product Name
- 百力特
- Approval Number
- 国药准字HJ20171244
- Approval Date
- Nov 4, 2022
NMPA
Botulinum Toxin Type A for Injection
- Product Name
- 保妥适
- Approval Number
- 国药准字SJ20171005
- Approval Date
- Jun 14, 2022
NMPA
Botulinum Toxin Type A for Injection
- Product Name
- 保妥适
- Approval Number
- 国药准字SJ20171003
- Approval Date
- Jun 14, 2022
NMPA
Botulinum Toxin Type A for Injection
- Product Name
- 保妥适
- Approval Number
- 国药准字SJ20171004
- Approval Date
- Jun 14, 2022
NMPA
Brimonidine Tartrate Eye Drops
- Product Name
- 阿法根
- Approval Number
- 国药准字HJ20160681
- Approval Date
- Jun 28, 2021
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found